Nanotechnology Drug Delivery Systems Market Worth USD 76.5 Billion by 2020, Research Study by iHealthcareAnalyst, Inc.
Summary
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site Press Releases iHealthcareAnalyst, Inc. Press Release Receive press releases from iHealthcareAnalyst, Inc.: By Email RSS Feeds: Nanotechnology Drug Delivery Systems Market Worth USD 76.5 Billion by 2020, Research Study by iHealthcareAnalyst, Inc. Maryland Heights, MO, September 30, 2016 --( Visit the Nanotechnology Drug Delivery Systems Market 2013-2020 report at http://www.ihealthcareanalyst.com/report/nanotechnology-drug-delivery-systems-market/ The global nanotechnology drug delivery systems market segmentation is based on technology types (nanocrystals, nanoparticles, dendrimers, gold nanoparticles, fullerenes, liposomes, micelles, nanotubes), and its applications (anti-infective, anti-inflammatory, immunology, cardiovascular, physiology, neurology, oncology).Quantom dots, chitosan, Polylactic/glycolic acid (PLGA) and PLGA-based nanoparticles have also been used for in vitro RNAi delivery.iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.Contact Us iHealthcareAnalyst, Inc. 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043 United States Email: sales@ihealthcareranalyst.com Website: http://www.ihealthcareanalyst.com Maryland Heights, MO, September 30, 2016 --( PR.com )-- According to a market research report Nanotechnology Drug Delivery Systems Market 2013-2020, published by iHealthcareAnalyst, Inc., the global nanotechnology drug delivery systems market is estimated to reach USD 76.5 Billion in 2020, expanding at a CAGR of 10.6% from 2016 to 2020.Visit the Nanotechnology Drug Delivery Systems Market 2013-2020 report at http://www.ihealthcareanalyst.com/report/nanotechnology-drug-delivery-systems-market/The global nanotechnology drug delivery systems market segmentation is based on technology types (nanocrystals, nanoparticles, dendrimers, gold nanoparticles, fullerenes, liposomes, micelles, nanotubes), and its applications (anti-infective, anti-inflammatory, immunology, cardiovascular, physiology, neurology, oncology).The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.Contact UsiHealthcareAnalyst, Inc.2109, Mckelvey Hill Drive,Maryland Heights, MO 63043United StatesEmail: sales@ihealthcareranalyst.comWebsite: http://www.ihealthcareanalyst.com Contact Information iHealthcareAnalyst, Inc. Ana Aitawa (314) 736-9294 http://www.ihealthcareanalyst.com/ Click here to view the list of recent Press Releases from iHealthcareAnalyst, Inc. Promote Your Business Press Release Pricing Email this page to a friend